US Stock MarketDetailed Quotes

TGTX TG Therapeutics

Watchlist
  • 16.510
  • +0.320+1.98%
Close May 6 16:00 ET
  • 16.500
  • -0.010-0.06%
Post 16:29 ET
2.55BMarket Cap55.03P/E (TTM)

About TG Therapeutics Company

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

Company Profile

SymbolTGTX
Company NameTG Therapeutics
Listing DateOct 7, 2005
Founded1993
CEOMr. Michael S. Weiss
MarketNASDAQ
Employees264
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address3020 Carrington Mill Boulevard,Suite 475
CityMorrisville
ProvinceNorth Carolina
CountryUnited States of America
Zip Code27560
Phone1-212-554-4484
Websitehttp://www.tgtherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Michael S. Weiss
  • Chairman of the Board, Chief Executive Officer and President
  • 15.84M
  • Sean A. Power
  • Chief Financial Officer, Treasurer and Corporate Secretary
  • 1.87M
  • Sagar Lonial, M.D.
  • Independent Director
  • 259.70K
  • Laurence N. Charney
  • Lead Independent Director
  • 304.70K
  • Kenneth Hoberman
  • Independent Director
  • 264.70K
  • Daniel Hume
  • Independent Director
  • 262.20K
  • Dr. Yann Echelard
  • Independent Director
  • 262.20K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg